CIK 0001360214 · Large accelerated filer
HARROW, INC.
Sign in to watch- Ticker
- HROW
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 450567010
- Phone
- 615.733.4731
- Business address
- 1A BURTON HILLS BLVD, SUITE 200, NASHVILLE, TN
- Former names
- HARROW HEALTH, INC., Imprimis Pharmaceuticals, Inc., TRANSDEL PHARMACEUTICALS INC, Bywater Resources, Inc
- 4 Open-market sale Director sold 10,000 shares at $10.75 ($107,500)
- DEFA14A Proxy Proxy Materials
- D Other Notice of Sales of Unregistered Securities
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- CERT Other Certification
- 8-K Event Material agreement · Agreement ended · New debt or obligation · Unregistered share sale · Shareholder rights changed · Bylaws or fiscal year change · Other events
- 4 Shares withheld for taxes Chief Financial Officer gave up 49,832 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Executive Officer gave up 334,129 shares (to pay taxes)
- SC 13D/A Stake Beneficial Ownership Report
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 8-A12B Other Registration of Securities
- 8-K Event Material agreement · New debt or obligation
- 305B2 Other 305B2
- 424B5 Offering Prospectus
- FWP Offering Free Writing Prospectus
- 8-K Event Results of operations · Regulation FD disclosure
- 424B5 Offering Prospectus
- 4 Open-market sale 10% owner sold 1,518,000 shares at $7.00 ($10,626,000)
Page 15 of 44 · 872 filings